Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Pravastatin")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1195

  • Page / 48
Export

Selection :

  • and

Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17NIEMI, Mikko; NEUVONEN, Pertti J; HOFMANN, Ute et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 5, pp 303-309, issn 1744-6872, 7 p.Article

PharmGKB: very important pharmacogene ― HMGCRWONG MEDINA, Marisa; SANGKUHL, Katrin; KLEIN, Teri E et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 2, pp 98-101, issn 1744-6872, 4 p.Article

Efficient Biotransformations Using Escherichia coli with tolC acrAB Mutations Expressing Cytochrome P450 GenesFUJII, Tadashi; FUJII, Yoshikazu; MACHIDA, Kazuhiro et al.Bioscience, biotechnology, and biochemistry. 2009, Vol 73, Num 4, pp 805-810, issn 0916-8451, 6 p.Article

The effect of SLCΟ1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent : the contribution of transporting activity changes by SLCΟ1B1 15JIAN WEI DENG; SONG, Im-Sook; HO JUNG SHIN et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 5, pp 424-433, issn 1744-6872, 10 p.Article

Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokineticsNIEMI, Mikko; AMOLD, Katja A; LANG, Thomas et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 11, pp 801-808, issn 1744-6872, 8 p.Article

Lipid lowering by pravastatin increases parasympathetic modulation of heart rate: Gαi2, a possible molecular marker for parasympathetic responsivenessWELZIG, C. Michael; SHIN, Dong-Gu; PARK, Ho-Jin et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 22, pp 2743-2746, issn 0009-7322, 4 p.Article

Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot studyRALLIDIS, Loukianos S; DRAKOULIS, Christos K; PARASI, Aikaterini S et al.Atherosclerosis. 2004, Vol 174, Num 1, pp 193-196, issn 0021-9150, 4 p.Article

Pravastatin-induced lichenoid drug eruption : Residents in dermatology: A focus on their patientsKEOUGH, G. C; RICHARDSON, T. T; GRABSKI, W. J et al.Cutis (New York, NY). 1998, Vol 61, Num 2, pp 98-100, issn 0011-4162Article

Postischemic administration of HMG CoA reductase inhibitor inhibits infarct expansion after transient middle cerebral artery occlusionSUGIURA, Shiro; YAGITA, Yoshiki; SASAKI, Tsutomu et al.Brain research. 2007, Vol 1181, pp 125-129, issn 0006-8993, 5 p.Article

Effects of pravastatin and bezafibrate on biliary lipid excretion and hepatic expression of Abcg5 and Abcg8 in the ratKAMISAKO, Toshinori; OGAWA, Hiroshi.Journal of gastroenterology and hepatology. 2004, Vol 19, Num 8, pp 879-883, issn 0815-9319, 5 p.Article

Pravastatin has an additional depressor effect in patients undergoing long-term treatment with antihypertensive drugsIKEDA, Toshio; SAKURAI, Jun; NAKAYAMA, Daisuke et al.American journal of hypertension. 2004, Vol 17, Num 6, pp 502-506, issn 0895-7061, 5 p.Article

Pravastatin reduces the incidence of cardiac events among patients with myocardial infarctionFURUTA, Hiroki; KIMURA, Akio; MIYATAKA, Masaru et al.Japanese heart journal. 2003, Vol 44, Num 6, pp 873-877, issn 0021-4868, 5 p.Article

Does aggressive statin therapy offer improved cholesterol-independent benefits compared to conventional statin treatment?GUPTA, Sandeep.International journal of cardiology. 2004, Vol 96, Num 2, pp 131-139, issn 0167-5273, 9 p.Article

Amelioration of cisplatin-induced nephrotoxicity by pravastatin in miceYI AN; HUI XIN; WEI YAN et al.Experimental and toxicologic pathology (Print). 2011, Vol 63, Num 3, pp 215-219, issn 0940-2993, 5 p.Article

Effect of drug transporter genotypes on pravastatin disposition in European-and African-American participantsHO, Richard H; CHOI, Leena; LEE, Wooin et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 8, pp 647-656, issn 1744-6872, 10 p.Article

Pharmacokinetic properties of pravastatin in Mexicans : An open-label study in healthy adult volunteersESCOBAR, Yesenia; VENTURELLI, Caterina R; HOYO-VADILLO, Carlos et al.Current therapeutic research. 2005, Vol 66, Num 3, pp 238-246, issn 0011-393X, 9 p.Article

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)NIEMI, Mikko; SCHAEFFELER, Elke; EICHELBAUM, Michel et al.Pharmacogenetics (London). 2004, Vol 14, Num 7, pp 429-440, issn 0960-314X, 12 p.Article

Lack of hypotension with lovastatin and provastatinKOSTIS, J. B; WILSON, A. C.Lancet (British edition). 1991, Vol 338, Num 8778, issn 0140-6736, p. 1339Article

Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15 + C1007G, by using transient expression systems of hela and HEK293 cellsKAMEYAMA, Yoshio; YAMASHITA, Keiko; KOBAYASHI, Kaoru et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 7, pp 513-522, issn 1744-6872, 10 p.Article

Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensisKÜCKELHAUS, Carlos S; KÜCKELHAUS, Selma As; IMACULADA MUNIZ-JUNQUEIRA, Maria et al.Experimental parasitology. 2011, Vol 127, Num 3, pp 658-664, issn 0014-4894, 7 p.Article

Treatment of HCC with pravastatin, octreotide, or gemcitabine: A critical evaluationLERSCH, C; SCHMELZ, R; ERDMANN, J et al.Hepato-gastroenterology. 2004, Vol 51, Num 58, pp 1099-1103, issn 0172-6390, 5 p.Article

Statins and newly diagnosed diabetesJICK, Susan S; BRADBURY, Brian D.British journal of clinical pharmacology. 2004, Vol 58, Num 3, pp 303-309, issn 0306-5251, 7 p.Article

Bénéfices additionnels de l'association pravastatine et aspirine sur la réduction des événements cardiovasculaires chez le patient coronarienBAUTERS, Christophe.La Lettre du cardiologue. 2006, Num DEC, pp 1-1, issn 0761-5035, 1 p., NSArticle

Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with Pravastatin in type II dyslipidemiaKUIVENHOVEN, Jan Albert; DE GROOTH, Greetje J; KAWAMURA, Hitoshi et al.The American journal of cardiology. 2005, Vol 95, Num 9, pp 1085-1088, issn 0002-9149, 4 p.Article

The effect of pravastatin and atorvastatin on coenzyme Q10BLESKE, Barry E; WILLIS, Richard A; ANTHONY, Mark et al.The American heart journal. 2001, Vol 142, Num 2, issn 0002-8703, p. 262Article

  • Page / 48